STAT

Opinion: As the world prepares to fight Lassa fever, the interests of pregnant women must be part of the planning

The interests of pregnant women weren't included in thinking about making and deploying a vaccine against Ebola. We can't make that same mistake with Lassa fever.
A transmission electron microscope reveals the size and shape of the virus that causes Lassa fever.

As health officials work to contain the continuing outbreak of Ebola in the Democratic Republic of Congo, lessons from that crisis can be applied to more equitably battle Lassa fever, another deadly infectious disease.

As 2019 begins, the Ebola outbreak in the DRC is a of tragic proportions. This outbreak, the second largest in history, disproportionally affects women of childbearing potential. Unfortunately, the only available Ebola vaccine has characteristics that make it problematic for use in women who are pregnant. Although they are at high risk of becoming infected and dying,

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Amylyx Pulling Its ALS Drug, GLP-1 Drugs For Parkinson’s, And More
Amylyx Pharmaceuticals will take its ALS drug Relyvrio off the market in the U.S. and Canada, ending a multi-year saga for patients with the rare neurodegenerative disease.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.

Related Books & Audiobooks